← FDA DRUG APPROVALS

FDA ANDA · ANDA074143

METOPROLOL TARTRATE

Sponsor: TEVA

APPLICATION
ANDA074143
TYPE
ANDA
ORIGINAL APPROVAL
1994-09-30
LATEST ACTION
1999-12-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 50MG · TABLET · ORAL
METOPROLOL TARTRATEDiscontinued
METOPROLOL TARTRATE 100MG · TABLET · ORAL

Approval history

1999-12-07Labeling · Supplement 7AP
1998-11-10Manufacturing (CMC) · Supplement 5AP
1998-11-10Manufacturing (CMC) · Supplement 4AP
1995-11-20Manufacturing (CMC) · Supplement 1AP
1995-11-20Labeling · Supplement 2AP
1995-08-02Manufacturing (CMC) · Supplement 3AP
1994-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →